NR3C1 and depressive disorder: Other evidence supporting this model includes the reports of glucocorticoid resistance, inflammation and depressive-like behaviours in the aforementioned repeated social defeat animal models of depression [45] and a study showing that administration of dexamethasone (a synthetic glucocorticoid and GR agonist) leads to reduced GR target gene expression in patients with depressive disorders and mouse models [2].